Amicus Therapeutics is a unique company that specializes in the treatment of rare conditions. Amicus is one of the leading companies in the world with advanced biotechnology facilities. Nasdaq has listed Amicus Therapeutics as FOLD. The company has devoted a lot of resources to research as they try to find solutions to the world’s most dreaded illnesses.
Amicus Therapeutics has developed numerous medications over the years. They are however renowned for producing migalastat, which is a medication designed to treat a rare disease known as Fabry. Besides migalastat, Amicus Therapeutics has also brought SD-101 into the market. SD-101 is the first medication available to the public that treats Epidermolysis Bullosa, which is a rare hereditary connective tissue disorder. Visit Google Finance to know more about Amicus Therapeutics.
Amicus Therapeutics has also been working on therapies for a broad range of diseases that include Pompe disease, Fabry disease, and several other lysosomal storage disorders. The company mostly embarks on programs that deal with devastating disorders or rare diseases. They also develop therapies that are better than the ones already in the market. Promising and complete customer-minded clinical data must also support their therapies.
Amicus Therapeutics is reputed for maintaining a good relationship with their patients, families, and caregivers. They keep in touch with their patients on a daily basis while monitoring their progress and how well they react to the medications and therapies. The company is consistently researching to come up with new technologies that will make the lives of their patients better.
Amicus Therapeutics understands that the fight against rare conditions can be challenging. The company works to support patients and communities around them by offering guidance on how to take care of their patients. Learn more about job offerings of Amicus Therapeutics at indeed.com.
The company employs qualified staff who have devoted their lives to remain open, honest and respectful to their patients. Most of the staff members are constantly looking for new ways to which they can help their patients.